Katsuyuki Takeda, MD, PhD

Katsuyuki Takeda
Associate Professor
Department of Pediatrics
Division of Cell Biology
Katsuyuki Takeda, MD, is a researcher at National Jewish Health. Dr. Takeda is in the Division of Cell Biology and Department of Pediatrics.

image descriptionPrograms & Services
Research AreasResearch Areas

Special Interests

Research Interests

Bronchial asthma; as asthma is the most common chronic inflammatory lung disease, I intend to elucidate the disease mechanisms and explore a new therapeutic approach.

Emphysema; as emphysema is a terminal stage of lung damage in lung diseases such as cigarette smoking-associated COPD or Alpha 1-antitrypsin deficiency, which is a genetic disease. My goal is to explore a novel therapeutic tool to repair and normalize damaged lung tissue.

Education

Education
Okayama Medical School, PhD
Tottori University, MD

Awards & Recognition

1998: Astra Research Grant (Competitive Grant for Asthma Research, Japan)
2010: ATS Grant “Alpha-1 Foundation Research Grant in Alpha-1”

Board Certification

Japanese Society of Internal Medicine 

Professional Memberships

American Thoracic Society (ATS)
Japanese Society of Internal Medicine

Publications

Takeda K, et al. Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation. Immune Netw. 2016;16:165-75.

Takeda K, et al. Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge. J Allergy Clin Immunol. 2015;135:451-460.

Takeda K, et al. The Critical Role of Complement Alternative Pathway Regulator Factor H in Allergen-Induced Airway Hyperresponsiveness and Inflammation. J Immunol. 2012 188:661-7. 9.     

Takeda K, et al. Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation. Br J Pharmacol, 2010, 160:1399-407. 14. 

Takeda K, et al. Vaccine-Induced CD8  T Cell-Dependent Suppression of Airway Hyperresponsiveness and Inflammation. J Immunol. 2009, 183:181-90.

Website Information

Takeda Lab

Conflicts of Interest

National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account
 

Contact Information

  • Office: 877.225.5654
  • Fax: 303.270.2182

 

Locations

  • National Jewish Health Main Campus
    1400 Jackson St.
    Denver, CO 80206

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.
 
 

Comments

Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.